Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

diet quality; ceramides; obesity; cardiovascular risk; healthy eating index; carbohydrate antigen-125; heart failure; inflammatory marker; older women; biomarker; cardiometabolic disease; epicardial adipose tissue; epicardial fat; epicardial fat volume; microRNA; thyroid-stimulating hormone; cardiometabolic risks; metabolic syndrome; hypertension; very low-density lipoprotein; STIM1; SOCE; atrial myopathy; atrial fibrillation; ejection fraction; soluble urokinase-type plasminogen activator receptor (suPAR); growth differentiation factor 15 (GDF-15); heart-type fatty acid-binding protein (H-FABP); soluble suppression of tumorigenicity 2 (sST2); acute myocardial infarction; biomarkers; catestatin; coronary artery disease; heart failure decompensation; left ventricular ejection fraction; troponin; NT-proBNP; NYHA functional class; GDF-15; cardiovascular surgery; operative risk; muscle wasting; sarcopenia; renal dysfunction; chronic kidney disease; aortic disease; aneurysm; miRNA; TGF-β pathway; KLF4; synthetic phenotype; aortic regurgitation; echocardiography; magnetic resonance imaging; vena contracta area; longitudinal strain; T1 mapping; GDF8; myostatin; AMI; ceruloplasmin; H-FABP; heart-type fatty acid-binding protein; FABP3; fatty acid-binding protein 3; HF; cardiac biomarkers; cardiac magnetic resonance imaging; left ventricular systolic function; magnetic resonance spectroscopy; myocardial triglyceride content; cell adhesion molecule; repeated measurements; pregnancy-associated plasma protein-A; cohort studies; cardiovascular diseases; mitochondrial dysfunction; circulating cells; PBMCS; platelets; oxidative stress; reactive oxygen species (ROS); mitochondrial DNA (mtDNA); herat failure; liver-type fatty-acid-binding protein; long-term outcomes; cardiac intensive care units; acute kidney injury; myocardial infarction; STEMI; cardiovascular events; cardiovascular death; risk stratification; sST2; Pentraxin-3; sudden cardiac death; ventricular arrhythmia; ventricular tachycardia; chronic heart failure; saliva; salivary biomarkers; CKD; CVD; PPCI; left ventricular adverse remodelling; circulating miRNAs; NAFLD; Framingham risk score; risk prediction; secondary prevention; primary prevention; NAFLD fibrosis score; HFpEF; HFrEF; suPAR; n/a